Niox trading in line with expectations
Niox Group
67.00p
12:39 20/06/24
-1.76%
-1.20p
Asthma-focussed medical device company Niox said in an update on Wednesday that it continued to perform strongly in the year to date, meeting management expectations.
FTSE AIM 100
3,729.82
13:05 20/06/24
n/a
n/a
FTSE AIM 50
4,221.75
13:05 20/06/24
n/a
n/a
FTSE AIM All-Share
773.91
13:05 20/06/24
n/a
n/a
Health Care Equipment & Services
11,262.36
13:04 20/06/24
0.85%
95.04
The AIM-traded firm, which was holding its annual general meeting, noted that it settled returns claims totaling £0.4m in January, related to its discontinued business operations.
As of 30 April, the unaudited cash balance for Niox was £23.7m, up from £19.9m at the end of December 2023, with the company maintaining a debt-free status.
Niox said it would provide a trading update for the six months ending 30 June in mid-July.
At 1240 BST, shares in Niox Group were up 1.1% at 73.4p.
Reporting by Josh White for Sharecast.com.